| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |